Hawkins Richard J — SEC Form 4 filings
SEC reporting owner CIK 1307632. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-05 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings — 63,412 shares, $123,080 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 8,000 shares, $26,569 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: purchase of 48,225 shares @ $2.04 ($98,572) in Savara Inc, filed 2025-06-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Savara Inc (SVRA) | Director | 4 | 1 leg · 48,225 sh · $98,572 | 1 leg · 8,000 sh · $26,569 | 4 |
| PLUS THERAPEUTICS, INC. (PSTV) | Director | 9 | 3 legs · 15,187 sh · $24,508 | — | 9 |
| LUMOS PHARMA, INC. | Chief Executive Officer, Director | 3 | — | — | 12 |
Form 4 filings — Hawkins Richard J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-11-17 | 4 | Savara Inc (SVRA) | Option exercise (M): 5,860 @ $1.46 · Option exercise (M): 5,860 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 397,794 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Savara Inc (SVRA) | Purchase (P): 48,225 @ $2.04 | EDGAR |
| 2025-02-20 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 40,122 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 · Sale (S): 8,000 @ $3.32 | EDGAR |
| 2024-12-13 | 4 | LUMOS PHARMA, INC. | Disposition to issuer (D): 753,093 · Disposition to issuer (D): 4,469 · Disposition to issuer (D): 19,624 (derivative) · Disposition to issuer (D): 35,400 (derivative) · Disposition to issuer (D): 35,400 (derivative) · Disposition to issuer (D): 135,000 (derivative) · +2 more | EDGAR |
| 2024-09-17 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 4,000 @ $1.50 | EDGAR |
| 2024-09-16 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 6,285 @ $1.35 | EDGAR |
| 2024-09-12 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,650 (derivative) @ $0 | EDGAR |
| 2024-05-10 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 4,902 @ $2.04 · Grant/award (A): 9,804 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | LUMOS PHARMA, INC. | Grant/award (A): 4,500 @ $2.84 · Tax withholding (F): 1,522 @ $2.84 · Grant/award (A): 35,400 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 2,250 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | LUMOS PHARMA, INC. | Tax withholding (F): 690 @ $3.01 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1307632 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →